{"title":"Trastuzumab: preparation and planning will avoid chaos","authors":"Steve Chaplin MRPharmS","doi":"10.1002/fps.19","DOIUrl":null,"url":null,"abstract":"<p>Trastuzumab has been shown to improve disease-free, and overall, survival in women with early HER2-positive breast cancer. It is undergoing rapid appraisal by NICE with the aim of providing prompt guidance for use within the NHS. The DOH has pledged to support its use, yet without increasing PCT funding for support services and additional drug costs. The criteria by which PCTs can decide or decline to pay for treatment remain unclear. Copyright © 2006 John Wiley & Sons, Ltd.</p>","PeriodicalId":100566,"journal":{"name":"Future Prescriber","volume":"7 1","pages":"7-12"},"PeriodicalIF":0.0000,"publicationDate":"2008-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/fps.19","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Future Prescriber","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/fps.19","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Trastuzumab has been shown to improve disease-free, and overall, survival in women with early HER2-positive breast cancer. It is undergoing rapid appraisal by NICE with the aim of providing prompt guidance for use within the NHS. The DOH has pledged to support its use, yet without increasing PCT funding for support services and additional drug costs. The criteria by which PCTs can decide or decline to pay for treatment remain unclear. Copyright © 2006 John Wiley & Sons, Ltd.
曲妥珠单抗:准备和计划将避免混乱
曲妥珠单抗已被证明可以改善早期her2阳性乳腺癌女性的无病生存率和总体生存率。NICE正在对其进行快速评估，目的是为NHS的使用提供及时的指导。卫生部已承诺支持其使用，但不增加用于支助服务和额外药品费用的PCT资金。pct决定或拒绝支付治疗费用的标准仍不清楚。版权所有©2006 John Wiley &儿子,有限公司
本文章由计算机程序翻译，如有差异，请以英文原文为准。
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
